These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16280688)

  • 1. Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain.
    Hedden T; Gabrieli JD
    Curr Opin Neurol; 2005 Dec; 18(6):740-7. PubMed ID: 16280688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples.
    Doan NT; Engvig A; Zaske K; Persson K; Lund MJ; Kaufmann T; Cordova-Palomera A; Alnæs D; Moberget T; Brækhus A; Barca ML; Nordvik JE; Engedal K; Agartz I; Selbæk G; Andreassen OA; Westlye LT;
    Neuroimage; 2017 Sep; 158():282-295. PubMed ID: 28666881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
    Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images.
    Lorenzi M; Pennec X; Frisoni GB; Ayache N;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S42-52. PubMed ID: 25311276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Sperling R
    Ann N Y Acad Sci; 2007 Feb; 1097():146-55. PubMed ID: 17413017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
    Reinvang I; Espeseth T; Westlye LT
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
    Solé-Padullés C; Bartrés-Faz D; Junqué C; Vendrell P; Rami L; Clemente IC; Bosch B; Villar A; Bargalló N; Jurado MA; Barrios M; Molinuevo JL
    Neurobiol Aging; 2009 Jul; 30(7):1114-24. PubMed ID: 18053618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
    Teipel SJ; Bokde AL; Born C; Meindl T; Reiser M; Möller HJ; Hampel H
    Brain; 2007 Jul; 130(Pt 7):1745-58. PubMed ID: 17566054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why musical memory can be preserved in advanced Alzheimer's disease.
    Jacobsen JH; Stelzer J; Fritz TH; Chételat G; La Joie R; Turner R
    Brain; 2015 Aug; 138(Pt 8):2438-50. PubMed ID: 26041611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging as a marker of the onset and progression of Alzheimer's disease.
    Masdeu JC; Zubieta JL; Arbizu J
    J Neurol Sci; 2005 Sep; 236(1-2):55-64. PubMed ID: 15961110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
    Fjell AM; Amlien IK; Westlye LT; Stenset V; Fladby T; Skinningsrud A; Eilsertsen DE; Bjørnerud A; Walhovd KB
    Neuroimage; 2010 Jan; 49(2):1820-30. PubMed ID: 19800012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.